Ochre Bio appoints 10 physicians, researchers following $30M funding round

Liver disease therapeutics company Ochre Bio has assembled a 10-member scientific strategy board following the close of a $30 million series A funding round. 

Advertisement

Ten physician, researcher leaders at Ochre Bio: 

1. Sangeeta Bhatia, MD, PhD — Wilson Professor of Engineering at Massachusetts Institute of Technology in Cambridge 

2. Chinwe Ukomadu, MD, PhD — Senior vice president and head of GI therapeutics at Takeda

3. Chas Bountra, PhD — Pro vice chancellor for innovation and professor of translational medicine at  the University of Oxford (England)

4. Scott Friedman, MD — Professor and chief of the division of liver sciences at Mount Sinai in New York City

5. Troy Dale — Head of the strategic partnerships unit at Novartis 

6. Joel Dudley, PhD — Partner at Innovation Endeavors 

7. Michael Hodges, MD — RNA therapeutics consultant

8. Leanne Hodson, PhD — Professor of metabolic physiology at the University of Oxford

9. Eduardo Martins, MD, PhD — chief medical officer at Sagimet

10. Alex Shalek, PhD — Core member of the Institute for Medical Engineering and Science

“True to Ochre’s philosophy of highly transdisciplinary expertise from technology through to biology, we are honored to have a strong group of advisors who will challenge us to do the best possible science and help us advance our therapies to patients,” Quin Wills, PhD, chief scientific officer and co-founder of Ochre Bio, said in an Oct. 20 press release. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership

Advertisement

Comments are closed.